Integrated Quantitative Investments LLC bought a new stake in shares of Crocs, Inc. (NASDAQ:CROX - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 8,100 shares of the textile maker's stock, valued at approximately $887,000.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in Crocs by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 5,477,574 shares of the textile maker's stock worth $599,959,000 after acquiring an additional 47,576 shares in the last quarter. Pacer Advisors Inc. increased its stake in shares of Crocs by 39.6% in the fourth quarter. Pacer Advisors Inc. now owns 2,037,121 shares of the textile maker's stock worth $223,126,000 after purchasing an additional 577,467 shares in the last quarter. State Street Corp raised its position in shares of Crocs by 0.7% during the 3rd quarter. State Street Corp now owns 1,812,493 shares of the textile maker's stock valued at $262,467,000 after purchasing an additional 13,467 shares during the period. Arrowstreet Capital Limited Partnership lifted its stake in shares of Crocs by 1,516.1% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,326,564 shares of the textile maker's stock valued at $145,299,000 after buying an additional 1,244,480 shares in the last quarter. Finally, Geode Capital Management LLC boosted its holdings in Crocs by 1.4% in the 4th quarter. Geode Capital Management LLC now owns 1,064,644 shares of the textile maker's stock worth $116,644,000 after buying an additional 15,037 shares during the period. 93.44% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In other news, EVP Adam Michaels sold 15,000 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $106.69, for a total value of $1,600,350.00. Following the completion of the sale, the executive vice president now owns 89,323 shares of the company's stock, valued at approximately $9,529,870.87. This represents a 14.38 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Shannon Sisler sold 4,659 shares of Crocs stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $109.75, for a total transaction of $511,325.25. Following the transaction, the executive vice president now directly owns 29,299 shares in the company, valued at approximately $3,215,565.25. The trade was a 13.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.72% of the company's stock.
Crocs Trading Down 4.8 %
Shares of NASDAQ:CROX traded down $4.82 during trading hours on Monday, hitting $95.83. 3,237,563 shares of the company's stock traded hands, compared to its average volume of 1,426,198. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.18 and a quick ratio of 0.70. The business has a fifty day moving average price of $102.96 and a 200-day moving average price of $111.78. Crocs, Inc. has a 1 year low of $88.25 and a 1 year high of $165.32. The firm has a market capitalization of $5.37 billion, a P/E ratio of 5.99, a price-to-earnings-growth ratio of 1.80 and a beta of 1.62.
Crocs (NASDAQ:CROX - Get Free Report) last issued its earnings results on Thursday, February 13th. The textile maker reported $2.52 EPS for the quarter, topping analysts' consensus estimates of $2.27 by $0.25. Crocs had a net margin of 23.16% and a return on equity of 46.27%. Equities analysts expect that Crocs, Inc. will post 13.2 earnings per share for the current year.
Analysts Set New Price Targets
Several equities analysts have recently commented on CROX shares. Loop Capital boosted their price objective on Crocs from $110.00 to $125.00 and gave the company a "buy" rating in a research report on Tuesday, April 1st. Barclays dropped their price target on Crocs from $125.00 to $122.00 and set an "overweight" rating for the company in a research note on Friday, February 14th. UBS Group lifted their price objective on shares of Crocs from $122.00 to $132.00 and gave the company a "neutral" rating in a research report on Wednesday, February 19th. Guggenheim dropped their target price on shares of Crocs from $155.00 to $150.00 and set a "buy" rating for the company in a research report on Monday, February 3rd. Finally, StockNews.com downgraded shares of Crocs from a "buy" rating to a "hold" rating in a report on Thursday, February 20th. Four analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $144.53.
Get Our Latest Analysis on CROX
Crocs Profile
(
Free Report)
Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.
Recommended Stories

Before you consider Crocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crocs wasn't on the list.
While Crocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report